Find articles by Koehler, J
Some of the diagnoses which have been impossible to treat- autoimmune, inflammatory, vague symptoms- may be improved by GLPs, EBO2, and other newer cutting edge treatments
DH-04 returned a significant result of 316 m at 0.097% nickel-in-alloy, from 10 m below surface
It is worth noting that tirzepatide's mechanism of slowing gastric emptying could theoretically exacerbate reflux symptoms in susceptible individuals, and acid reflux can occasionally cause throat irritation
Subcutaneous injection protocol: Starting dose: 200 to 300 mcg daily Titration: Increase by approximately 100 mcg every 1 to 2 weeks as tolerated Target dose: 400 to 500 mcg daily by weeks 5 through 12 Frequency: Once daily, subcutaneous Cycle length: 8 to 12 weeks, with optional extension to 16 weeks Timing: Consistent daily timing, typically evening for sleep applications Oral/sublingual protocol: Duration: 30 days Frequency: 1 to 4 cycles per year Best combined with: Exercise and nutrient-rich diet Injection sites should be rotated between the abdomen, thighs, and upper arms to prevent lipohypertrophy and ensure consistent absorption
